Prophylactic tocilizumab reduces the incidence of cytokine release syndrome in relapsed/refractory myeloma patients treated with teclistamab: Implications for outpatient step‐up dosing-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prophylactic tocilizumab reduces the incidence of cytokine release syndrome in relapsed/refractory myeloma patients treated with teclistamab: Implications for outpatient step‐up dosing

Published:2024-07 Issue:7 Volume:8 Page:
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:HemaSphere

Author:

Korst Charlotte L. B. M.¹²^ORCID,Groen Kaz¹²^ORCID,Bosman Patricia W. C.¹²,van der Valk Fleur³,Verkleij Christie P. M.¹²,Kruyswijk Sandy¹²,de Ruijter Maaike E. M.¹²,Heijink Dianne M.¹²,Kuipers Maria T.¹²,Zweegman Sonja¹²,van de Donk Niels W. C. J.¹²^ORCID

Affiliation:

1. Department of Hematology, Amsterdam UMC Vrije Universiteit Amsterdam Amsterdam The Netherlands

2. Cancer Biology and Immunology Cancer Center Amsterdam Amsterdam The Netherlands

3. Department of Hematology Onze Lieve Vrouwe Gasthuis Amsterdam The Netherlands

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hem3.132

Reference15 articles.

1. Teclistamab in Relapsed or Refractory Multiple Myeloma

2. Long-term follow-up from MajesTEC-1 of teclistamab, a B-cell maturation antigen (BCMA) x CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM).

3. T-cell-engaging bispecific antibodies in cancer

4. Detailed overview of incidence and management of cytokine release syndrome observed with teclistamab in the MajesTEC‐1 study of patients with relapsed/refractory multiple myeloma

5. ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP